Japan
Taisho Pharma to buy Bristol-Myers Squibb’s consumer health business in deal worth $1.6 bn
December 19, 2018Business Services BMS, Japan, M&A, MA, Taisho, deal
Japanese company Taisho Pharmaceuticals has offered Bristol-Myers Squibb $1.6 billion for its UPSA consumer health business. With more than a …
Takeda shareholders approve $62bn Shire acquisition
December 6, 2018Business Services Ireland, Japan, M&A, MA, Shire, Takeda, acquisition
Japanese firm Takeda have gained shareholders’ approval for the $62 billion acquisition of the Irish headquartered company Shire Plc. The …
Japan approves AstraZeneca’s Tagrisso in EGFRm non-small cell lung cancer
August 21, 2018Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, Japan, Tagrisso, lung cancer, pharma
AstraZeneca has revealed that its EGFR tyrosine kinase inhibitor Tagrisso (osimertinib) has been approved in Japan by the nation’s Ministry …
Astellas acquires gene therapy group Quethera in £85 million deal
August 13, 2018Sales and Marketing Astellas, Japan, gene therapy, ocular, quethera, vision
The Japanese company Astellas Pharma has acquired British gene therapy group Quethera in a deal worth up to £85 million. …
Takeda to sell Osaka site to soften Shire deal’s financial impact
July 5, 2018Manufacturing and Production, Sales and Marketing Japan, Osaka, Shire, Takeda, acquisition, pharma
It’s one of the biggest acquisitions the industry has seen at a total value of $63 billion and after weeks …
Takeda’s Entyvio secures Japanese approval in ulcerative colitis
July 2, 2018Sales and Marketing Entyvio, Japan, Takeda, pharma, ulcerative colitis
Takeda Pharmaceutical has announced that its monoclonal antibody, Entyvio (vedolizumab), has been approved for the treatment of patients with moderately …
Takeda move for Shire looks increasingly likely
April 6, 2018Medical Communications, Sales and Marketing Japan, Shire, Takeda, UK, biotech, drugs, pharma, pharmaceutical
Takeda’s surprise announcement, just last week, that it was weighing up a move for Shire had some analysts sceptical about …
GSK’s shingles vaccine secures EU and Japan approvals
March 26, 2018Sales and Marketing EU, Europe, GSK, Japan, Shingrix, pharma, shingles
GlaxoSmithKline has announced that its shingles vaccine Shingrix has secured approval in two new regions: in Europe, for the prevention …
Takeda completes construction of new global headquarters in Tokyo
March 21, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Japan, Takeda, pharma, tokyo
Japan’s biggest pharmaceutical firm Takeda has announced the completion of construction of its new global headquarters in the country’s capital …
Top Ten most popular articles on Pharmafile.com this week
March 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Biogen, Celgene, EMA, Gilead, HIV, Herceptin, Japan, NHS, Ontruzant, Sanofi, opioid crisis, opioids, pharma, real world data, top ten, zinbryta
After a particularly jarring bout of cold weather and snow, we may just have seen off the worst of winter …
Japan saves record $12.2bn in 2017 through greater generic use
March 7, 2018Research and Development, Sales and Marketing Japan, generics, keytruda, opdivo, pharma
Through a concerted shift from branded drugs to generic equivalents as a means to lower prescription costs, Japan is estimated …
AstraZeneca scores double approvals in Japan for asthma and ovarian cancer
January 19, 2018Medical Communications, Sales and Marketing AstraZeneca, Cancer, Fasenra, Japan, asthma, lynparza, ovarian cancer, pharma
AstraZeneca has unveiled a double dose of approvals awarded to its medicines in Japan: Fasenra (benralizumab) has been given authorisation …
Japanese pharma expects 17% growth throughout 2017
April 25, 2017Manufacturing and Production CPhI, Japan
Pharma companies attending CPhI Japan are expecting a 17% growth of the country’s market throughout the year, according to data …
Japan announces measure to crack down on drug pricing
December 20, 2016Manufacturing and Production, Medical Communications Japan, Shinzo Abe, opdivo
Japan has committed to annual drug price reviews whilst also expanding the scope by which the prices are deemed to …
Japan to slash Opdivo costs by 50%
November 17, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Japan, opdivo
Japan’s health ministry has announced it is to slash the price of Bristol-Myers Squibb’s Opdivo by 50% in the country …
Latest content
